TrialCancer science2019

Efficacy and safety of nivolumab in Japanese patients with uterine cervical cancer, uterine corpus cancer, or soft tissue sarcoma: Multicenter, open-label phase 2 trial.

Kenji Tamura et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.